CONCLUSION: ChatGPT-4 and ChatGPT-3.5 are potentially powerful tools in immuno-oncology, whereas Google Bard demonstrated relatively poorer performance. However, the risk of inaccuracy or incompleteness in the responses was evident in all 3 LLMs, highlighting the importance of expert-driven verification of the outputs returned by these technologies.PMID:38309720 | DOI:10.1093/oncolo/oyae009
Source: The Oncologist – Category: Cancer & Oncology Authors: Giovanni Maria Iannantuono Dara Bracken-Clarke Fatima Karzai Hyoyoung Choo-Wosoba James L Gulley Charalampos S Floudas Source Type: research
